Purpose Various resin cements and priming agents are available for adhesive luting of zirconia restorations. The purpose of this study was to investigate how cement type and priming protocol affect the shear bond strength on zirconia ceramics. Materials and Methods Yttria‐stabilized tetragonal zirconia polycrystalline ceramic cylinders were bonded to flat zirconia ceramic surfaces using 7 commercially available resin cements. Ten specimens of each cement group were pretreated with a universal primer, and 10 specimens per group were bonded without pretreatment. In addition, 10 specimens per group were pretreated with system‐specific zirconia primers, which were available for 3 cements. Altogether, 170 bonded specimens were water‐stored, thermal‐cycled, and then submitted to shear bond strength tests. The shear bond strength and the fracture types were documented. Differences in shear bond strengths were assessed using 2‐way ANOVA with post‐hoc test (α = 0.05). A point‐biserial correlation was run between the fracture patterns and the shear bond strengths. Results The mean shear bond strengths of cements in the unprimed group showed large variations between 2.52 ± 3.01 (mean ± SD) MPa and 33.15 ± 7.35 MPa. Pretreating the specimens with a universal primer improved the shear bond strengths significantly in all groups (p < 0.05) with a range of 21.80 ± 12.51 to 57.20 ± 11.40 MPa. The system‐specific primers also improved the shear bond strength significantly, compared to the unprimed group (p < 0.01); however, only one system‐specific primer achieved a shear bond strength superior to the universal primer (p < 0.01). There was also a statistical correlation between the fracture type and the shear bond strength (p < 0.0005), with cohesively fractured specimens showing higher shear bond strengths (37.24 ± 19.87 MPa) than adhesively fractured specimens (23.10 ± 17.65 MPa) (p < 0.001). Conclusion Using universal primer can enhance the maximal shear bond strength of zirconia.

Background Orthodontic treatment with fixed appliances is often necessary to correct malocclusions in adolescence or adulthood. However, oral hygiene is complicated by appliances, and prior studies indicate that they may trigger oral inflammation and dysbiosis of the oral microbiota, especially during the first 3 months after insertion, and, thus, may present a risk for inflammatory oral diseases. In recent periodontal therapeutic studies, probiotics have been applied to improve clinical parameters and reduce local inflammation. However, limited knowledge exists concerning the effects of probiotics in orthodontics. Therefore, the aim of our study is to evaluate the impact of probiotics during orthodontic treatment. Methods This study is a monocentric, randomized, double blind, controlled clinical study to investigate the effectiveness of daily adjuvant use of Limosilactobacillus reuteri (Prodentis®-lozenges, DSM 17938, ATCC PTA 5289) versus control lozenges during the first three months of orthodontic treatment with fixed appliances. Following power analysis, a total of 34 adolescent patients (age 12–17) and 34 adult patients (18 years and older) undergoing orthodontic treatment at the University Hospital Erlangen will be assigned into 2 parallel groups using a randomization plan for each age group. The primary outcome measure is the change of the gingival index after 4 weeks. Secondary outcomes include the probing pocket depth, the modified plaque index, the composition of the oral microbiota, the local cytokine expression and—only for adults—serum cytokine levels and the frequencies of cells of the innate and adaptive immune system in peripheral blood. Discussion Preventive strategies in everyday orthodontic practice include oral hygiene instructions and regular dental cleaning. Innovative methods, like adjuvant use of oral probiotics, are missing. The aim of this study is to analyse, whether probiotics can improve clinical parameters, reduce inflammation and prevent dysbiosis of the oral microbiota during orthodontic treatment. If successful, this study will provide the basis for a new strategy of prophylaxis of oral dysbiosis-related diseases during treatment with fixed appliances. Trial registration This trial is registered at ClinicalTrials.gov in two parts under the number NCT04598633 (Adolescents, registration date 10/22/2020), and NCT04606186 (Adults, registration date 10/28/2020).

No abstract